Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Sarcoma, Kaposi 2Sarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Melanoma 2Hemangioma, Capillary 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Lymphatic Metastasis 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Propranolol 2propranolol mustard 1Timolol 1Lasers, Solid-State 1Lasers 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemangioma, Capillary × Propranolol × 1 year × Clear all
NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

West China Hospital

Phase 2/3 Recruiting
40 enrolled

Ulcer, Hemangioma, Capillary

NCT07104526 2025-08-05

Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)

Wuhan Integrated Traditional Chinese and Western Medicine Hospital

Phase NA Completed
260 enrolled

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡